Deepika Pakianathan, Director at Alder Biopharmaceuticals, holds 0.00 shares in Karyopharm Therapeutics (Ticker: KPTI), holds 47.42K shares in Theravance Biopharma (Ticker: TBPH), holds 0.00 shares in Calithera Bio (Ticker: CALA). Most recently, Deepika Pakianathan Sold ― shares of Karyopharm Therapeutics on Jun 07, 2024 for an estimated value of 780.70K.
What was Deepika Pakianathan’s latest transaction?
Deepika Pakianathan latest transaction was an Informative Sell of $780.70K.
What was Deepika Pakianathan's most profitable transaction?
Deepika Pakianathan’s most profitable transaction was an Informative Buy of ALDR stock on May 13, 2014. The return on the trade was 241.70%.
What is Deepika Pakianathan's role in Alder Biopharmaceuticals?
Deepika Pakianathan's role in Alder Biopharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.